EDAN Further Emphasizes Importance of Deep Regional Development at Hospitalar 2024

EDAN Further Emphasizes Importance of Deep Regional Development at Hospitalar 2024

Sao Paulo, Brazil, May 23, 2024 – Edan Instruments, Inc. (300206. SZ), a leading healthcare company and medical device manufacturer, demonstrated its commitment to regional growth at Hospitalar 2024, Latin America’s premier healthcare expo. The event, held at Expo Sao Paulo from May 21 to 24, 2024, attracted more than 90,000 professionals and 60,000 industry personnel.

In the ultrasound segment, the upcoming launch of the compact and innovative Nano Series handheld system marks a major leap forward for EDAN’s portable ultrasound technology. Attendees were amazed by its user-friendly interface and advanced imaging capabilities, creating considerable buzz throughout the event.

In addition to the Nano Series, the Acclarix AX9 Portable Diagnostic Ultrasound System also attracted attention for its sleek design and powerful performance. The Acclarix AX9 Portable Diagnostic Ultrasound System is a portable diagnostic ultrasound system powered by the cutting-edge SynSight regional ultrasound platform. With its stylish design and powerful performance, the system has gained wide attention, solidifying EDAN’s reputation as a pioneer in portable imaging solutions.

EDAN’s latest iV Series modular monitors took center stage with features such as real-time PresCCO continuous cardiac output, providing caregivers with a critical tool for acute care.

Additionally, EDAN highlighted its commitment to innovation in animal care with the launch of the H90X Vet Hematology Analyzer. The device has generated significant interest among veterinary professionals. Its user-friendly interface and accurate results make it an outstanding solution for veterinary clinics and laboratories seeking efficient hematology analysis.

With a strategic focus on Latin America, São Paulo is an important hub for EDAN’s healthcare endeavors. By participating in events such as Hospitalar, EDAN underscores its commitment to sharing cutting-edge medical technology and improving access to healthcare throughout the region.